1. P159/O30 OLT1177™, an oral NLRP3 inflammasome inhibitor, inhibits acute joint inflammation and circulating IL 1β during gout flares in humans. (March 2019) Authors: Klück, V; Janssen, M; Jansen, TL; Tengesdal, IW; Schraa, K; Skouras, DB; Marchetti, C; Dinarello, CA; Joosten, LA Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗